Delivery Order SPE2DB22D2214-SPE2DB25FS5VE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $54,649.34 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine,...
- The Defense Logistics Agency awarded a delivery order valued at $11,213.10 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a $5,211.52 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. NURTEC ODT...
- The Defense Logistics Agency awarded a delivery order valued at $1,948.56 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the agency's continued procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,179.65 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on April 24, 2025, with completion scheduled for April 25, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,655.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on June 6, 2025, with completion scheduled for June 9, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5VEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,855.70 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pharmaceutical procurement supporting federal medical supply requirements. The contract contains no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an expansive $999.99 billion prime vendor agreement running through December 2026 that supplies pharmaceutical products and medical commodities globally to military healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills diverse therapeutic needs across the Defense Health Agency and military healthcare networks through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. This particular delivery order for migraine treatment represents a routine execution within the company's comprehensive pharmaceutical support mission for federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 7/18/25 |